CONDITIONS OF RESEARCH. To simplify the surveillance of COVID-19 in society and monitor the spread of mutations of the virus, the University of Gothenburg is now establishing a unique database. It will coordinate large amounts of data about the virus and share this information among hospitals and universities throughout Sweden and with the Swedish Public Health Agency. “We will be able to follow trends nationally and in the near future…
National research program on the effects of COVID-19 vaccines – two projects at the University of Gothenburg
COMBATING COVID-19. The Knut and Alice Wallenberg Foundation is investing SEK 53 million on a national research program to study the effects of COVID-19 vaccines. Of the 10 projects receiving funding, two are being led by researchers at the University of Gothenburg. Anna Lundgren is coordinating a project on immune response after vaccination among individuals who were previously infected by COVID-19, individuals who were unexposed, and immunosuppressed individuals. Fredrik Nyberg…
A new hub for developing medicines of the future at the University of Gothenburg
CONDITIONS OF RESEARCH. In recent years, techniques have been developed to treat diseases with what are known as oligonucleotide drugs, based on short DNA or RNA molecules. The Wallenberg Centre for Molecular and Translational Medicine at the University of Gothenburg has now been awarded SEK 54 million by the Knut and Alice Wallenberg Foundation, and SEK 48m from SciLifeLab and the University of Gothenburg, to create a national technology platform…
Eight COVID-19 projects led from Gothenburg with support from SciLifeLab
GRANTS. Reserchers in Gothenburg are leading eight of the projects related to COVID-19 that have now received funding through the initiative from SciLifeLab and the Knut and Alice Wallenberg Foundation. Just after the start of the pandemic, SciLifeLab, together with the Knut and Alice Wallenberg Foundation (KAW), launched a national challenge for researchers to create a comprehensive research program in nine fields to fight the disease. The call totaled SEK…
A research leader of the future establishes a team in Gothenburg
YOUNG RESEARCHERS. After six years in the United States, Linda Johansson is back at Medicinareberget in Gothenburg. With advanced microscopy methods, she will study the interaction between two receptors for melatonin in the brain. Eventually, the research can lead to better treatments of type 2 diabetes and other ailments. Linda Johansson is one of the young researchers recently named as a research leader of the future by the Swedish Foundation…